Guia de Medicamentos

109 artigos

Todos os artigos
Guia de Medicamentos

GLP-1 Dose Tracker: Log Your mg & Titration Schedule

A GLP-1 dose tracker logs which milligram you took on which date and follows your titration — Wegovy 0.25→2.4, Zepbound 2.5→15. See how to track and share it.

5 min de leitura
Guia de Medicamentos

GLP-1 Shot Tracker: Log Every Weekly Injection & Site

A GLP-1 shot tracker logs each weekly injection — date, rotated site, and missed-dose window for Wegovy, Ozempic & tirzepatide. See exactly how to track a shot.

5 min de leitura
Guia de Medicamentos

Injection Tracker App for GLP-1: Features to Look For

Choosing an injection tracker app for GLP-1? Here are the must-have features — site-rotation body map, weekly reminders, dose log, missed-dose logic — and why it beats paper.

5 min de leitura
Guia de Medicamentos

Oral Wegovy Side Effects: Nausea & Warnings (2026)

Oral Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild-to-moderate and worst during dose increases. Because oral Wegovy is the same molecule as injectable Wegovy (semaglutide), it shares the *same* side-effect profile and the *same* serious warnings, including pancreatitis, gallbladder disease, and a boxed thyroid warning.

10 min de leitura
Guia de Medicamentos

Orforglipron Side Effects: Nausea, Warnings (2026)

Orforglipron's most common side effects are gastrointestinal — nausea, diarrhea, constipation, and vomiting — which are dose-dependent, tend to be worst around each dose increase, and usually settle as the body adapts. Rare but serious risks include a boxed warning for thyroid C-cell tumors plus pancreatitis and gallbladder disease, which need urgent medical care.

8 min de leitura
Guia de Medicamentos

Retatrutide Side Effects: Trial Data & Warnings 2026

In clinical trials, retatrutide's most common side effects are gastrointestinal — nausea, diarrhea, constipation, and vomiting — mostly mild-to-moderate and worst during dose escalation. Its triple-agonist design also produces two distinctive signals: abnormal skin sensations (dysesthesia) and a modest heart-rate increase. Retatrutide is investigational and available only through clinical trials — it cannot be prescribed.

7 min de leitura
Guia de Medicamentos

Oral Wegovy Tracker: What to Track on the Pill (2026)

An oral Wegovy tracker logs your daily dose, the empty-stomach fasting window, weight trend, protein & side effects. Here's what to track on the Wegovy pill.

10 min de leitura
Guia de Medicamentos

Semaglutide vs Tirzepatide: Which Is Right for You? (2026)

Tirzepatide (Mounjaro, Zepbound) acts on two hormones (GIP + GLP-1) and produced greater average weight loss in trials (~21%) than semaglutide (Ozempic, Wegovy, ~15%). But semaglutide has the longer track record and strong cardiovascular data. The "better" one depends on your goals, tolerance, cost, and prescriber.

4 min de leitura
Guia de Medicamentos

GLP-1 Side Effects: Ozempic, Wegovy & Tirzepatide Guide (2026)

The most common GLP-1 side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and abdominal pain — and they are usually mild, most likely when starting or increasing the dose, and tend to ease within a few weeks. Rare but serious risks include pancreatitis, gallbladder problems, and severe delayed stomach emptying, which need urgent medical attention.

8 min de leitura
Guia de Medicamentos

How Much Does Wegovy & Ozempic Cost in 2026? Full Price Breakdown

Without insurance, Ozempic and Wegovy have list prices of roughly $970–$1,350 per month. But almost nobody pays that. Through the manufacturer's cash-pay pharmacy (NovoCare), self-pay prices in 2026 are about $349–$499/month for the injection and $149–$299/month for the newer oral pill — and with commercial insurance plus a savings card, eligible patients can pay as little as $0–$25 a month.

7 min de leitura
Guia de Medicamentos

Mounjaro Side Effects: Nausea, Sulfur Burps & Timeline (2026)

Mounjaro's most common side effects are gastrointestinal — nausea, diarrhea, decreased appetite, vomiting, and constipation — usually mild and worst during dose increases. Many users also report sulfur ("egg") burps. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying.

9 min de leitura
Guia de Medicamentos

Ozempic Side Effects: Nausea, Timeline & Warnings (2026)

Ozempic's most common side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and abdominal pain — usually mild and worst during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent care.

9 min de leitura
Guia de Medicamentos

Semaglutide Side Effects: Ozempic, Wegovy & Rybelsus (2026)

Semaglutide's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Frequency depends on the product and dose: highest with Wegovy 2.4 mg (weight loss), lower with Ozempic and oral Rybelsus (diabetes). Rare serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying.

10 min de leitura
Guia de Medicamentos

Tirzepatide Side Effects: Mounjaro & Zepbound (2026)

The most common tirzepatide side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent medical care.

9 min de leitura
Guia de Medicamentos

Wegovy Side Effects: Nausea, Hair Loss & Timeline (2026)

Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Because Wegovy titrates to a higher 2.4 mg dose, these are reported more often than with Ozempic. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying.

10 min de leitura
Guia de Medicamentos

Wegovy Tracker: What to Track on Wegovy & How (2026)

A Wegovy tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on semaglutide and why it matters.

7 min de leitura
Guia de Medicamentos

Zepbound Side Effects: Nausea, Hair Loss & Timeline (2026)

Zepbound's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Injection-site reactions and hair loss are also labeled. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent care.

11 min de leitura
Guia de Medicamentos

GLP-1 Sozinho Não É Suficiente — O Modelo "Medicamento + Terapia Comportamental" Recomendado pela OMS/ADA, e os Estágios M0/M1/M2 do HAVIT

Agonistas do receptor GLP-1 (Wegovy, Mounjaro, Zepbound) produzem perda de peso média de 15–22% (STEP 1, SURMOUNT-1). Mas o STEP 4 relatou reganho de +11,6%p um ano após descontinuação — cerca de 78% da perda de peso retornou. A OMS (2022) e ADA Standards (2024) recomendam explicitamente terapia comportamental junto com farmacoterapia, e o STEP 3 (JAMA 2021) mostrou que a Terapia Comportamental Intensiva em combinação alcançou quase 3× a perda de peso da combinação com cuidado padrão (−16% vs −5,7%). O HAVIT estrutura isso em 3 estágios — pré-medicação (M0), adaptação (M1), manutenção/descontinuação (M2) — integrando medicamentos, preservação muscular e aprendizado comportamental. O HAVIT não prescreve GLP-1; prescrição, dosagem e descontinuação permanecem no domínio do médico.

14 min de leitura

Pronto para emagrecer de forma mais inteligente?

Tudo o que você precisa para perder peso, preservar músculo e criar hábitos saudáveis — em um só app com IA.

Download on the App StoreGet it on Google Play

Download gratuito. Pode conter compras no aplicativo.